All stock reports

BAFNAPH evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

Research only

1 opportunity assessments; compare evidence and conditions below.

Event Gap Reaction

Research only. Direction: LONG.

Tests whether a material opening gap is accepted rather than immediately rejected

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Gap fill and reversal below prior close
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-28T23:40:35.778819+00:00

Metrics

latest_annual_period
2026-03-31
revenue
1506174000.0
net_income
110998000.0
operating_cash_flow
118265000.0
free_cash_flow
-130763000.0
total_assets
1755324000.0
total_liabilities
793829000.0
total_equity
961495000.0
cash
20245000.0
total_debt
374333000.0
revenue_growth
0.03263744626586318
earnings_growth
1.6730403371462974
net_margin
0.07369533666097011
roe
0.11544313802983895
debt_to_equity
0.3893239174410683
cash_conversion
1.0654696481017676
free_cash_flow_margin
-0.08681799048449913
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-2cf7115d4e722829d8f2b06ff8346f5e39e117a34fddd173c34731777d5d01e8
Policy
stock-decisions-v1
Evidence bundle hash
9d69b56151fc5e4389fb99e2f6c73e2992570f43e98f4c3358b662d4408d8f09
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 56178ba460fffb75c569fd645e1ff91f65b4f533d68822ec75732859951ce0b4
  • daily-price: 04bfceeaeaff9b552bf003833bd99341dc0858f2b10414decd9f4e131f728c76
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 5-session price return was 10.36%. The trailing 20-session price return was 22.97%. The trailing 60-session price return was 85.62%. The trailing 250-session price return was 125.53%. Average cached traded value over twenty sessions was INR 1,463,517.

Risks

The cached financial metric free cash flow margin is -0.08681799048449913. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.03263744626586318. The cached financial metric net margin is 0.07369533666097011. The cached financial metric roe is 0.11544313802983895. The cached financial metric debt to equity is 0.3893239174410683. The closing price was 0.00% below its highest close in the available trailing year.

Cached observations and evidence limits